OnDemand WTP Pricing Research

Lannett (LCI) Completes Voluntary Strategic Review – Affirms Acting in Compliance on Digoxin Pricing | Street Insider

According to the subpoena, the Connecticut Attorney General is investigating whether anyone engaged in any activities that resulted in (a) fixing, maintaining or controlling prices of digoxin or (b) allocating and dividing customers or territories relating to the sale of digoxin in violation of Connecticut antitrust law.

“We have and will continue to fully cooperate with the Connecticut Attorney General’s ongoing investigation. Furthermore, we acted quickly to conduct an exhaustive review of our pricing practices,” said Arthur Bedrosian, president and chief executive officer of Lannett. “Results of the review, which included the examination of well over 700,000 documents, confirm our belief that the company has and continues to adhere to applicable laws and regulations with regard to pricing of digoxin. We took the inquiry from the Connecticut Attorney General very seriously and conducted the review, in part, to demonstrate to our stockholders and employees that we have acted in compliance with all applicable rules and regulations regarding the pricing of digoxin.”

Read complete article here:

Lannett (LCI) Completes Voluntary Strategic Review; Affirms Acting in Compliance on Digoxin Pricing.

Post a Comment

WP-SpamFree by Pole Position Marketing